Literature DB >> 24028437

Blockage of Nrf2 suppresses the migration and invasion of esophageal squamous cell carcinoma cells in hypoxic microenvironment.

H Shen1, Y Yang, S Xia, B Rao, J Zhang, J Wang.   

Abstract

Nuclear factor erythroid-2-related factor 2 (Nrf2) is a critical cell protector by inducing phase two detoxifying and anti-oxidant enzymes in normal cells. But recently, numerous evidence show Nrf2 may play the same beneficial roles toward the cancer cells. Nrf2 is found upexpressed in lots of cancers and promote the proliferation and drug resistance. But studies about the role of Nrf2 in the metastases are few. It has been testified that the tumor cells are under hypoxic conditions. As an important anti-oxidant element, the expression of Nrf2 may be upregulated, which in turn promotes the tumor invasion and metastases in the hypoxic microenvironment. Our team found the expression of Nrf2 correlated with the lymph node metastasis of esophageal squamous cell carcinoma by pathological sections of esophageal carcinoma patients. Further, the mechanism beneath it was studied in this paper. It was hypothesized that the hypoxia microenvironment transformed Nrf2 a friend to a foe. First, Eca-109 cells were treated with different concentration of CoCl2 . Western blot and quantitative reverse transcription-polymerase chain reaction showed that with the increase of the concentration of CoCl2 , the expression levels of Nrf2 and hypoxia-inducible factor-1 (HIF-1) alpha were upregulated simultaneously. By analyzing the data, a significant correlation between Nrf2 and HIF-1 alpha in the protein levels was found. Further, blockage of Nrf2 mediated by shRNA suppressed the expression of HIF-1 alpha, hemeoxygenase-1 (HO-1), and matrix metalloproteinase 2 but enhanced the expression of E-cadherin. In addition, the results of wound healing and invasion assay-verified blockage of Nrf2 suppressed the migration and invasion. So it was suggested that blockage of Nrf2 repressed the migration and invasion of esophageal squamous cell carcinoma cells in the hypoxic microenvironment. HIF-1 alpha might be one of the downstream genes of Nrf2 regulated through Nrf2/HO-1 axis in the CoCl2 model. Nrf2 inhibition suppressed matrix metalloproteinase 2 and enhanced E-cadherin partly through HIF-1 alpha way.
© 2013 Wiley Periodicals, Inc. and the International Society for Diseases of the Esophagus.

Entities:  

Keywords:  ESCC; Nrf2; hypoxic microenvironment; migration and invasion

Mesh:

Substances:

Year:  2013        PMID: 24028437     DOI: 10.1111/dote.12124

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  28 in total

Review 1.  NRF2 and the Hallmarks of Cancer.

Authors:  Montserrat Rojo de la Vega; Eli Chapman; Donna D Zhang
Journal:  Cancer Cell       Date:  2018-05-03       Impact factor: 31.743

Review 2.  The multifaceted role of NRF2 in cancer progression and cancer stem cells maintenance.

Authors:  Bo-Hyun Choi; Jin Myung Kim; Mi-Kyoung Kwak
Journal:  Arch Pharm Res       Date:  2021-03-22       Impact factor: 4.946

Review 3.  Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target.

Authors:  Shaohua Ma; Chorlada Paiboonrungruan; Tiansheng Yan; Kevin P Williams; M Ben Major; Xiaoxin Luke Chen
Journal:  Ann N Y Acad Sci       Date:  2018-05-11       Impact factor: 5.691

4.  PSMD12 promotes glioma progression by upregulating the expression of Nrf2.

Authors:  Zhongyong Wang; Zhiyu Li; Hui Xu; Yun Liao; Chao Sun; Yanming Chen; Minfeng Sheng; Qing Lan; Zhong Wang
Journal:  Ann Transl Med       Date:  2021-04

5.  Comparative analysis of NRF2-responsive gene expression in AcPC-1 pancreatic cancer cell line.

Authors:  Yong Weon Yi; Seunghoon Oh
Journal:  Genes Genomics       Date:  2014-12-05       Impact factor: 1.839

6.  The anti-oxidative transcription factor Nuclear factor E2 related factor-2 (Nrf2) counteracts TGF-β1 mediated growth inhibition of pancreatic ductal epithelial cells -Nrf2 as determinant of pro-tumorigenic functions of TGF-β1.

Authors:  Geeske Genrich; Marcus Kruppa; Lennart Lenk; Ole Helm; Anna Broich; Sandra Freitag-Wolf; Christoph Röcken; Bence Sipos; Heiner Schäfer; Susanne Sebens
Journal:  BMC Cancer       Date:  2016-02-25       Impact factor: 4.430

7.  TCF11 Has a Potent Tumor-Repressing Effect Than Its Prototypic Nrf1α by Definition of Both Similar Yet Different Regulatory Profiles, With a Striking Disparity From Nrf2.

Authors:  Meng Wang; Yonggang Ren; Shaofan Hu; Keli Liu; Lu Qiu; Yiguo Zhang
Journal:  Front Oncol       Date:  2021-06-29       Impact factor: 6.244

8.  Nrf2 Down-Regulation by Camptothecin Favors Inhibiting Invasion, Metastasis and Angiogenesis in Hepatocellular Carcinoma.

Authors:  Qian Liu; Shanshan Zhao; Fanguang Meng; Hankang Wang; Liwei Sun; Guijie Li; Feng Gao; Feng Chen
Journal:  Front Oncol       Date:  2021-06-09       Impact factor: 6.244

9.  The Crosstalk between Nrf2 and TGF-β1 in the Epithelial-Mesenchymal Transition of Pancreatic Duct Epithelial Cells.

Authors:  Sarah Arfmann-Knübel; Birte Struck; Geeske Genrich; Ole Helm; Bence Sipos; Susanne Sebens; Heiner Schäfer
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

Review 10.  Cytoprotection "gone astray": Nrf2 and its role in cancer.

Authors:  Claudia Geismann; Alexander Arlt; Susanne Sebens; Heiner Schäfer
Journal:  Onco Targets Ther       Date:  2014-08-26       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.